Stewart, Julian M <br/><br/>
Intradermal angiotensin II administration attenuates the local cutaneous vasodilator heating response.  [electronic resource] 

 -  American journal of physiology. Heart and circulatory physiology  Jul 2008 
 - H327-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0363-6135 
<br/><br/><label>Standard No.: </label>10.1152/ajpheart.00126.2008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Cutaneous<br/>Adult<br/>Angiotensin II--administration & dosage<br/>Angiotensin II Type 1 Receptor Blockers--administration & dosage<br/>Angiotensin II Type 2 Receptor Blockers<br/>Antioxidants--administration & dosage<br/>Ascorbic Acid--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Enzyme Inhibitors--administration & dosage<br/>Female<br/>Hot Temperature<br/>Humans<br/>Imidazoles--administration & dosage<br/>Infusions, Parenteral<br/>Losartan--administration & dosage<br/>Male<br/>Microdialysis<br/>Nitric Oxide--metabolism<br/>Nitric Oxide Synthase--antagonists & inhibitors<br/>Nitroarginine--administration & dosage<br/>Pyridines--administration & dosage<br/>Receptor, Angiotensin, Type 2--metabolism<br/>Regional Blood Flow<br/>Skin--blood supply<br/>Skin Temperature<br/>Vasoconstrictor Agents--administration & dosage<br/>Vasodilation--drug effects